BMS’s repotrectinib to have FoundationOne genomic sequencing companion diagnostic
Pharmaceutical Technology
APRIL 12, 2023
FoundationOne CDx is a sequencing-based in vitro diagnostic device that can identify alterations in 324 genes from tumour samples. With advances in DNA sequencing, such as the technology developed by Foundation Medicine, the genetic profiles of lung cancer patients could be annotated to then select appropriate treatment options.
Let's personalize your content